CBD for Cancer
Although the use of medical cannabis for cancers remains unsubstantiated, Cannabidiol has surprisingly attracted growing interest from researchers, the medical community, and patients over the past few years. Most people know that cannabinoids are therapeutic for a lot of serious ailments. With that said, there aren’t any significant clinical trials investigating the use of cannabis or cannabinoids as a cancer treatment. A few small research studies exist, but the research is still in its early stages.
While the initial results from small studies of CBD and cancer cells and CBD are promising, they are not conclusive. Unfortunately, Cancer and the treatment of Cancer can lead to pain. Cancer often causes pain due to pressure on internal organs, inflammation, or nerve injury. When the pain is extreme, it can become resistant to potent pain relievers like opioids. Due to some of the unwanted effects of cancer treatments, many people have started thinking about the potential therapeutic effects of Cannabidiol and other available treatment therapies.
One of the most significant advantages of medical cannabis and CBD Dosages over other conventional cancer therapies is that CBD, based on limited research, has shown thus far not to cause harm to healthy cells. This is important because it allows the patient to live a better quality of life. Recent studies have also shown that medical cannabis is as effective and potential as conventional cancer therapies. Although dosing with CBD has not been accepted as an alternative in the treatment options, some research has yielded positive results to prove the therapeutic abilities of CBD for Cancer. This is because CBD does not affect the central nervous system in the way that opiates do. The cannabinoid receptors in the brain react differently than many of the other drug receptors. For this reason, there may be a lower risk of side effects. In addition, unlike traditional medications for pain management, there are no known lethal doses of CBD.
With that said, a study carried out on mice and rats by the National Cancer Institute has shown preliminary results that medical cannabis might possess anti-tumor properties. The research further revealed that the abnormal growth of blood vessels and cells that tumors require might be blocked, leading to the death of harmful cells. Although these studies were not carried out on humans but mice, the results are promising and potentially show off the therapeutic effects of CBD on cancer cells.
The Cannabis / Hemp plant comprises hundreds of cannabinoids; it is a complex plant with over 400 chemical entities. More than 60 of them are cannabinoid compounds, some of which have opposing effects and inevitably indicate potential treatment prospects for Cancer. Researchers have found that several clinical studies and investigations have found that CBD Dosages may effectively treat various cancers. Cannabinoid receptors, CB1 and CB2, are binding sites of CBD and are possibly effective against multiple types of cancer cells.
This therapeutic effect occurs primarily due to the inhibition of the abnormal growth of cancer cells by preventing the formation of increasingly more blood vessels and preventing them from metastasizing. Please see the recent study at https://pubmed.ncbi.nlm.nih.gov/22624859. In addition, the activity of the cannabinoids initiates apoptosis to fight cancer cells. This implies that cannabinoids create cellular machinery where healthy cells eliminate unhealthy cells that could be cancerous.
Although Cannabinoid dosages may be a possible treatment for Cancer, delta-9-tetrahydrocannabinol or THC, in contrast, can suppress the immune system in some patients, inducing the escalation of cancer cells. Therefore, more research is needed to determine who will benefit most from before cannabis and CBD.
The treatment of cannabinoids with most ailments, including Cancer, is based on more anecdotal evidence at the moment. However, the passing of the 2018 Farm Bill is an essential first step in changing federal policy surrounding clinical research for both hemp and cannabis in general. In the meantime, various clinical trials are being conducted across the country, and we’ll continue to use this as a basis to help patients with multiple ailments, including Cancer. One initial study, carried out in 2011, showed that Cannabinoids are killing breast cancer cells without additionally having the undesirable effect of killing good or healthy cells, unlike other conventional cancer therapies. Although this study was mainly done on breast cancer cells, it also looks suitable for different kinds of Cancer.
In summary, limited critical human trials on which cancers respond to the treatment of cannabinoids have slowed down the process of getting CBD on the list of official cancer therapy options. While CBD is far from being considered a cancer treatment, it has undoubtedly proven advantageous in treating many forms of Cancer and potentially the effects of chemotherapy. As studies continue to evolve, there is light at the end of the tunnel.